New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2014
07:15 EDTICPTIntercept shares should be bought amid biotech weakness, says Oppenheimer
After meeting with Intercept's management, Oppenheimer believes that the company's management successfully explained issues involving OCA lipids, and the firm is now more confident in the company's ability to deal with future regulatory uncertainties. Oppenheimer keeps an Outperform rating on the stock.
News For ICPT From The Last 14 Days
Check below for free stories on ICPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
17:05 EDTICPTOrbiMed reports 7% stake in Intercept
Subscribe for More Information
August 26, 2014
07:46 EDTICPTIntercept Pharmaceuticals volatility at low end of historic range
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use